iTeos Therapeutics

$41.79
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.04 (+2.55%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell ITOS and other stocks, options, and ETFs commission-free!

About ITOS

iTeos Therapeutics, Inc. engages in the development of biopharmaceuticals therapeutic products and services. It offers immuno-oncology therapeutics for patients. The company was founded by Michel Detheux in April 2012 and is headquartered in Cambridge, MA. The listed name for ITOS is iTeos Therapeutics, Inc. Common Stock.

CEO
Michel Detheux
Employees
—
Headquarters
Cambridge, Massachusetts
Founded
2012
Market Cap
1.44B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
164.83K
High Today
$42.99
Low Today
$38.98
Open Price
$40.89
Volume
218.21K
52 Week High
$43.69
52 Week Low
$17.50

ITOS Earnings

-$29.49
-$19.66
-$9.83
$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 25, Pre-Market

You May Also Like

DWUS
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure